Schedule 13G ownership disclosure

Raptor Pharmaceutical Corp

Security class unavailable · CUSIP: 75382F106

Event date: 2014-03-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,619,987
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000897204-14-000006
Form type
SC 13G
Filer
Ivanishvili Bidzina
CIK
CIK 1608345
Filed
Jun 02, 2014
Reporting period
Mar 25, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub